Express Scripts

Visiox Pharma Appoints Richard J. Rubino to Board of Directors

Retrieved on: 
Thursday, August 17, 2023
Glaucoma, Audit committee, Medco, Certified Public Accountant, Express Scripts, Accounting, Patient, Growth, Medco Health Solutions, Pager (company), Disease, Pharmaceutical industry, Management, Manhattan College

TARRYTOWN, N.Y., Aug. 17, 2023 /PRNewswire/ -- Visiox Pharmaceuticals, Inc., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to address highly prevalent diseases in need of new treatment options, is pleased to announce that Richard J. Rubino has been appointed to serve on the Company's Board of Directors as the Chairman of the Audit Committee. Rubino brings over three decades of expertise driving enterprise-wide financial strategy.

Key Points: 
  • "Richard's appointment marks another significant milestone achievement for Visiox," said Ryan Bleeks, Chief Executive Officer.
  • "I am excited to join the Visiox Board and to guide the company through their financial strategy as they scale," stated Rubino.
  • Rubino served as Chief Financial Officer for Aerie Pharmaceuticals, Inc. from 2012 to 2021, with its initial public offering in 2013.
  • Rubino also held executive positions with Medco Health Solutions, serving as Chief Financial Officer until Medco merged with Express Scripts.

Visory Health CEO and Founder Susan Lang Named to 2023 Forbes 50 Over 50 List

Retrieved on: 
Tuesday, August 8, 2023
Linda, Inc., BJC HealthCare, Female, Pharmacy, Woman, Thought, Express Scripts, Lang, American Cancer Society, Pharmaceutical industry, Pfizer

ORLANDO, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Visory Health , a prescription discount card and healthcare technology company improving access to affordable medications to everyone, today announces its founder and CEO, Susan Lang , has been honored and recognized on the prestigious Forbes 50 Over 50 list.

Key Points: 
  • ORLANDO, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Visory Health , a prescription discount card and healthcare technology company improving access to affordable medications to everyone, today announces its founder and CEO, Susan Lang , has been honored and recognized on the prestigious Forbes 50 Over 50 list.
  • Lang began her entrepreneurial career as the founder of HooPayz in 2012, then built a leading strategic analytics and technology consulting firm, XIL Health, in 2013.
  • Prior to being named on the 2023 Forbes 50 Over 50 list, Lang was recognized by Inc. last year 100 Female Founder.
  • For more information on Visory Health, visit www.visoryhealth.com or download their app on the Google and Apple Play Store.

Preventing Pharmaceutical Price-Gouging: MSP Recovery Claims Proceed to Class Certification Against One of the Largest U.S. Pharmacy Benefit Managers in “Infamous” Case

Retrieved on: 
Wednesday, August 9, 2023
Legal, Parenting, Children, Baby, Maternity, Professional Services, Health, Consumer, Pharmaceutical, General Health, Clayton Antitrust Act of 1914, Sherman Antitrust Act, Spasm, Plaintiff, Pharmacy, 13th (Western) Division, MSP, Martin PBM Mariner, Hon, District court, Express Scripts, Complaint, Court, FDA, ACTH, Douglas v. U.S. District Court ex rel Talk America, Express, Pharmaceutical industry, Mallinckrodt, Adrenocorticotropic hormone (medication)

The court denied Defendants Express Scripts, Inc. et al.’s (“Express Scripts”) motion to dismiss allowing the Plaintiffs to proceed to class certification.

Key Points: 
  • The court denied Defendants Express Scripts, Inc. et al.’s (“Express Scripts”) motion to dismiss allowing the Plaintiffs to proceed to class certification.
  • Acthar’s manufacturer, Mallinckrodt, acquired the product in 2001 when Acthar sold for $40.00 per vial.
  • John H. Ruiz, CEO and Founder of MSP Recovery Inc. d/b/a LifeWallet (NASDAQ: LIFW), stated: “This is price-gouging, plain and simple.
  • No one should be forced to pay $39,000 per vial for the life-saving medicine on the market.

Express Scripts Names Head of Independent Pharmacy Affairs to Deepen Partnerships, Expand Access to Care

Retrieved on: 
Tuesday, August 8, 2023
Learning, CI, Pharming, Pharmacist, Express Scripts, Patient, Wilkes University, PBM, Cooney, Nursing care plan, NYSE, Management, Health care, Pharmacy

Building on Express Scripts' IndependentRx Initiative announced earlier this year, Cooney will expand the company's efforts to support the important role independent pharmacists play as a front line of care in many local communities.

Key Points: 
  • Building on Express Scripts' IndependentRx Initiative announced earlier this year, Cooney will expand the company's efforts to support the important role independent pharmacists play as a front line of care in many local communities.
  • By expanding pharmacy benefits and increasing access to a range of preventive care services at the pharmacy counter, patients will benefit through lower costs and added convenience.
  • Additionally, she will lead the newly established Independent Pharmacy Advisory Committee, which will convene a diverse group of pharmacy leaders across rural, urban and suburban areas.
  • "I am excited to bring my community pharmacy background to Express Scripts as we work together with independent pharmacies providing critical care and access to patients," said Cooney.

Girard Sharp LLP and Motley Rice LLC Announce a Proposed Settlement in In re Xyrem (Sodium Oxybate) Antitrust Litigation

Retrieved on: 
Friday, July 28, 2023
Amneal Pharmaceuticals, Damages, Lupin Limited, Class, Parent, Xywav, Nestlé USA, Inc. v. Doe, Person, Injunctive, District court, Settlement, Express Scripts, Court order, Punitive damages, Court, Defendant, City, Federal Employees Health Benefits Program, Tobacco, Insurance, Sodium oxybate

The plaintiffs in the lawsuit have reached a proposed Settlement with the Amneal and Lupin defendants that would resolve all claims against them.

Key Points: 
  • The plaintiffs in the lawsuit have reached a proposed Settlement with the Amneal and Lupin defendants that would resolve all claims against them.
  • Separately, the Court has certified several classes of Xyrem and/or Xywav payers and the claims of those classes against the remaining defendants will continue.
  • The proposed Settlement and the Court's class certification order may affect the rights of members of the Settlement Class, the Damages Class and the Injunctive Relief Class (all defined below).
  • But they give up any rights to sue the Defendants separately about the same legal claims in this lawsuit.

Arbitration Ruling Validates AHF Antitrust Theory Against PBM Prime Therapeutics

Retrieved on: 
Friday, July 14, 2023
Infectious Diseases, Advocacy Group Opinion, Public Policy, Government, Healthcare Reform, AIDS, White House, Federal Government, Health, Pharmaceutical, AHF, American Arbitration Association, HIV/AIDS, Express Scripts, Illegal per se, Pharmacy, Plasma protein binding, PBM, Blue Shield, Patient, AIDS Healthcare Foundation, Risk, Blue Cross, Ridesharing, Health insurance

AHF defeated Prime’s attempt to end the entire case and will be allowed to move forward against Prime on claims of antitrust violations and other civil wrongs.

Key Points: 
  • AHF defeated Prime’s attempt to end the entire case and will be allowed to move forward against Prime on claims of antitrust violations and other civil wrongs.
  • “The arbitrator’s ruling is particularly noteworthy for validating AHF’s theory of per-se (automatic) antitrust violations in the nature of price-fixing by Prime.
  • AHF is now preparing to prove those claims, in the next phase of the arbitration,” said Jonathan M. Eisenberg, Deputy General Counsel for AHF.
  • Since 2020, AHF has filled hundreds of thousands of drug prescriptions for patients whose PBM is Prime.

Mostafa Kamal to succeed Ken Paulus as Prime Therapeutics' President and Chief Executive Officer

Retrieved on: 
Monday, July 3, 2023
Risk management, Medicare Part D, Pharmacy, Rutgers University, Medicare, Express Scripts, Patient, PBM, HCSC, Growth, Health, Therapy, Economics, Pharmaceutical industry, Management

EAGAN, Minn., July 3, 2023 /PRNewswire/ -- Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, today announced that Mostafa Kamal will succeed Ken Paulus as President and CEO of Prime Therapeutics.

Key Points: 
  • EAGAN, Minn., July 3, 2023 /PRNewswire/ -- Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, today announced that Mostafa Kamal will succeed Ken Paulus as President and CEO of Prime Therapeutics.
  • Kamal currently serves as president of Prime Therapeutics, and the CEO of Magellan Rx, a Prime Therapeutics company.
  • "As Prime seeks to reimagine pharmacy benefit management, he is the right person to build on the strong foundation Ken leaves as he retires."
  • Kamal played a key role in shaping the 2022 agreement that brought together Prime and Magellan Rx.

VillageMD Welcomes Richard Rubino as Chief Financial Officer

Retrieved on: 
Tuesday, June 27, 2023
General Health, Health, Practice Management, Health Technology, Managed Care, CFO, Rich, Medco, Express Scripts, Medco Health Solutions, Population health, Consultant, Management

VillageMD announced today that Richard Rubino will join the organization as chief financial officer (CFO) effective June 26.

Key Points: 
  • VillageMD announced today that Richard Rubino will join the organization as chief financial officer (CFO) effective June 26.
  • As CFO, Rubino will be responsible for enterprise-wide financials, investor relations, payer contracting and analytics.
  • “We’re thrilled to have Rich join VillageMD as he brings extensive financial planning, strategy and leadership experience,” said Tim Barry, CEO and Chair of VillageMD.
  • “I am excited to join VillageMD and help drive the enterprise to exceed its strategic plan and reach operational excellence at scale,” said Rubino.

Kore.ai Customer Conference Brings Together Industry Leaders, Analysts to Contemplate on the Future of User Experiences With AI Technologies

Retrieved on: 
Tuesday, June 13, 2023
Kore, Morgan Stanley, LLM, Partnership, VUX, Mphasis, Hallucination, GALE, Synthetic media, ChatGPT, PNC Financial Services, American Water, EBay, Research, Emotion, Conversation, Language, Future, Express Scripts, EX, Internet, Engineering, Generative, Gesture, AX, Distinguishing, Magic Quadrant, Calibration, Management, Customer service, Mobile phone, Sales

ORLANDO, Fla., June 13, 2023 /PRNewswire/ -- Kore.ai, the world's leading enterprise conversational AI platform and solutions company, unveiled a framework for rapid and large-scale adoption of conversational AI and generic AI use cases within global businesses through the use of generative AI and large language models (LLMs). The new framework, GALE (Generative AI LLM Platform for Enterprise), was announced as part of its new product stack at the conclusion of its two-day customer event, Kore Konversations, during May 25-26, 2023 in Orlando, Florida.

Key Points: 
  • As human experiences are centered around languages, technologies that excel in natural language usage will enable enterprises to foster great experiences for their customers, employees, agents and partners alike, he explained.
  • "Spoken words, visual signs and gestures are at the core of how we express our needs, feelings and emotions.
  • The emergence of generative AI and LLMs has added a new dimension by opening unlimited possibilities to create enriched experiences.
  • said Simms, who also delivered a keynote on how the unique confluence of conversational AI and generative AI technologies is redefining the customer experience trends across industries.

National Kidney Foundation Appoints Walmart Chief Medical Officer Dr. Wigneswaran to National Board of Directors

Retrieved on: 
Thursday, June 1, 2023
Fresenius Medical Care, Nephrology, MBA, Tufts University School of Medicine, Massachusetts Institute of Technology, Express Scripts, Walmart, Weill Cornell Medicine, Patient, Division, NKF, DaVita Inc., National Kidney Foundation, PBM, Management, Knowledge, Johnson & Johnson, Cornell University, National Board of Medical Examiners, Kidney disease, Safety, Nursing, Cigna

NEW YORK, June 1, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) is thrilled to announce the appointment of Dr. John Wigneswaran (Dr. Wig), Walmart's Chief Medical Officer, to NKF's National Board of Directors. In his role at Walmart, Dr. Wig leads safety, quality, and training, the Walmart Healthcare Research Institute, clinical program development, innovation, and medical affairs. Dr. Wig was nominated and approved at NKF's most recent Board meeting held in March. 

Key Points: 
  • NEW YORK, June 1, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) is thrilled to announce the appointment of Dr. John Wigneswaran (Dr. Wig), Walmart's Chief Medical Officer, to NKF's National Board of Directors.
  • In his role at Walmart, Dr. Wig leads safety, quality, and training, the Walmart Healthcare Research Institute, clinical program development, innovation, and medical affairs.
  • Dr. Wig joined Walmart from Cigna where he served as Chief Medical Officer for Express Scripts.
  • "I'm honored to join the NKF Board of Directors and very excited to help those dealing with kidney disease in any way I can," said Dr. Wigneswaran, Chief Medical Officer at Walmart.